Global Thrombectomy Devices Market – Industry Trends and Forecast to 2030

Análisis y tamaño del mercado de dispositivos de trombectomía

Según los registros de la OMS, las enfermedades crónicas son las principales causas de muerte y discapacidad a nivel mundial. Los dispositivos de trombectomía ofrecen muchos beneficios en términos de resultados indirectos, como la reducción del tamaño del infarto, el análisis de biomarcadores, la resolución del segmento ST y el flujo de trombólisis angiográfica en el infarto de miocardio (TIMI). Se prevé que el aumento de la demanda de procedimientos quirúrgicos mínimamente invasivos y las políticas de reembolso favorables para procedimientos neurovasculares y cardiovasculares impulsen la demanda de dispositivos de trombectomía mecánica durante el período de pronóstico.

Data Bridge Market Research analiza que el mercado de dispositivos de trombectomía, que fue de USD 1.3 mil millones en 2022, se disparará hasta USD 2.06 mil millones para 2030, y se espera que experimente una CAGR del 5,9% durante el período de pronóstico de 2023 a 2030. Además de los conocimientos sobre escenarios de mercado como valor de mercado, tasa de crecimiento, segmentación, cobertura geográfica y actores principales, los informes de mercado seleccionados por Data Bridge Market Research también incluyen análisis de expertos en profundidad, epidemiología de pacientes, análisis de canalización, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de dispositivos de trombectomía

Definición de mercado

Los dispositivos de trombectomía se utilizan para el tratamiento de la embolia pulmonar y las enfermedades arteriales periféricas. Actualmente, están ampliamente disponibles en numerosos tamaños y diámetros, según el área afectada. Algunos de los procedimientos de dispositivos de trombectomía más utilizados son la embolectomía quirúrgica, la embolectomía con balón y la embolectomía por aspiración.

Dinámica del mercado de dispositivos de trombectomía

Conductores

• Enorme tasa de casos cardíacos

Cada vez hay más casos de pacientes cardíacos que están impulsando el crecimiento del mercado. Por ejemplo, en 2022, el Centro para el Control y la Prevención de Enfermedades (CDC) afirmó que 805.000 personas sufrieron un ataque cardíaco en los EE. UU. De ellos, 605.000 son pacientes que sufren un primer ataque cardíaco y 200.000 son personas que ya habían sufrido un ataque cardíaco antes. Según los registros de un artículo publicado en la Biblioteca Nacional de Medicina en 2022, se afirma que en los EE. UU. mueren alrededor de 610.000 personas por enfermedades cardíacas cada año. La enfermedad coronaria es la principal causa de muerte en el mundo occidental y mata a más de 370.000 personas al año. Esto impulsa el crecimiento del mercado.

• Aumento del lanzamiento de nuevos dispositivos

El avance y el lanzamiento de nuevos dispositivos, como recuperadores de coágulos, dispositivos de succión y catéteres de aspiración basados ​​en tecnología avanzada para el ictus isquémico, están impulsando el crecimiento del mercado. Por ejemplo, en 2021, Phenox GmbH lanzó los dispositivos de trombectomía mecánica pRESET 6-50 en todo el mundo para impulsar su tecnología para el ictus isquémico agudo. Este producto tiene el recuperador de stent más largo de la cartera de productos fenoxi. NeuroVasv anunció en 2021 que NeuroVasc Technologies lanzará el sistema de trombectomía mecánica ENVI-SR (ENVI-SR), que es un recuperador de stent para la eliminación de coágulos de sangre en pacientes que sufren un ictus isquémico agudo debido a la oclusión de grandes vasos.

Oportunidades

• Adquisiciones aumentadas por varias organizaciones

There have been several acquisitions by multiple organizations and market players that is expanding the market growth. For instance, in July 2021, Surmodics, which is a leading provider of in vitro diagnostic technologies and medical devices, announced the acquisition of privately held Vetex Medical Limited. The Galway an Ireland-based medical device developer and manufacturer has focused completely on venous clot removal solutions. The transaction expands Surmodics’ thrombectomy portfolio with a second USFDA 510(k)-cleared device, the ReVene Thrombectomy Catheter. The ReVene mechanical thrombectomy catheter is precisely designed to remove large, mixed-morphology blood clots usually found with venous thromboembolism (VTE).

Restraints/Challenges

• High cost of thrombectomy devices

The high cost of thrombectomy devices, and the high risk of infection are expected to hamper the market expansion, due to price fluctuations and a scarcity of experienced experts. Furthermore, patient compatibility and other difficulties, the materials utilised to produce thrombectomy devices are not rapidly approved by several government authorities. The material that is used to make these implants is anticipated to be biocompatible and highly inert. Consequently, finding permission for these devices is tough for businesses.

This thrombectomy devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the thrombectomy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Thrombectomy Devices Market

The beginning of the COVID-19 pandemic has led to an increase in patients suffering from chronic diseases. This pandemic's effects on patients' health have increased huge cases of respiratory failures leading to deaths. At the beginning of the pandemic, a major decline in the use of mechanical thrombectomy was witnessed globally. Moreover, delay in treatments using mechanical thrombectomy because of infection control measures has as well negatively impacted the market. Although COVID-19 has disturbed numerous healthcare actions, the thrombectomy devices market continued to witness robust growth.

Recent Developments

• In 2022, Cernuous, part of Johnson & Johnson Medical Devices Companies, launched EMBOGUARD. It is a next-generation balloon guide catheter to be used in endovascular procedures in patients with acute ischemic stroke.
• In 2021, Penumbra Inc. announced that the CHEETAH clinical study of its Indigo System CA RX Catheter positively, which had met the primary endpoint,  confirmed high rates of blood flow restoration, blood clot removal, and myocardial perfusion along with percutaneous coronary intervention (PCI) in patients having high thrombus burden.

Thrombectomy Devices Market Scope

The thrombectomy devices market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Aspiration Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• Mechanical Thrombectomy Devices
• Others

Application

• Cardiovascular Thrombectomy
• Neurovascular Thrombectomy
• Peripheral Vascular Thrombectomy

End-user

• Hospitals
• Ambulatory Surgical Centers

Thrombectomy Devices Market Regional Analysis/Insights

The thrombectomy devices market is analyzed and market size insights and trends are provided by product type, application and end-user as referenced above.

The countries covered in the thrombectomy devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the thrombectomy devices market due to the pervasiveness of numerous pharmaceuticals and biotechnology companies while high pace in technology and rising geriatric population will increase region market growth.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of increasing number of geriatric population and rise in disposable income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The thrombectomy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for trauma devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the trauma devices market. The data is available for historic period 2011-2021.

Competitive Landscape and Global Thrombectomy Devices Market Share Analysis

The thrombectomy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to thrombectomy devices market .

Some of the major players operating in the thrombectomy devices market are:

• Medtronic (Ireland)
• Inari Medical, Inc (U.S.)
• AngioDynamics (U.S.)
• Terumo Corporation (Japan)
• Stryker (U.S.)
• Zimmer Biomet (U.S.)
• Boston Scientific Corporation (U.S.)
• BD (U.S.)
• Straub Medical AG (Switzerland)
• Penumbra, Inc (U.S.)
• Edwards Lifesciences Corporation (U.S.)
• ARGON MEDICAL. (U.S.)
• Teleflex Incorporated (U.S.)
• phenox GmbH (Germany)
• Acandis GmbH (Germany)
• Merit Medical Systems (U.S.)
• Bayer AG (Germany)
• Getinge AB (Sweden)
• Philips Healthcare (U.S.)

SKU-23666